Scholars Central

Research articlePublished 22 Jan 2025

Cytogenetic Features of Patients with de novo Acute Myeloid Leukemia in Kurdistan Region of Iraq

Authors: Gihan Hamasharif Hamad

Department of General Science, College of Basic Education, Salahaddin University-Erbil, Erbil, Iraq

Journal of Oncology Research and Treatment

Volume 10 · Issue 1 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: AML is a complex condition marked by the growth of immature cells of the myeloid origin. There is currently minimal data on the mutational spectrum of AML patients in Kurdistan Region of Iraq. Methods: Samples from peripheral blood and bone marrow were collected from 100 AML patients and used for cytogenetic analysis. Fluorescence in situ Hybridization (FISH) using probes for detection of 5q, 7q, 3q, t(9;11), t(8;21), 11q23, t(6;11), t(15;17), and inv(16) chromosomal abnormalities for disease risk-stratification and classify AML. Results: The median age was 37 with AML-M2 makes up 43% of all cases. Chromosomal aberrations were observed in 48% of patients. The most prevalent structural abnormality was t(8;21) in 14% of patients, followed by inv(16), t(15;17), 11q23 translocations, and inv(3) in 7% and 5%, and 3% and 2% respectively. In terms of numerical abnormalities, +8 was found in 7% of cases followed by loss of sex chromosomes (6%), +11 (3%), +21 (2%), and each -7/del(7q) and -5/del (5q) in 1%. Additional chromosomal abnormalities commonly found with t(8;21), t(15;17) and inv(16) were present in 12%, 4% and 4% of cases consequently. 28% of patients were classified as having favorable risk, 64% as having intermediate risk, and 8% as having adverse risk. Conclusion: Here we provide the initial presentation of a cytogenetic profile of Kurdistan Region of Iraqi individuals who have newly developed AML. Findings can help in accurate diagnostic and improves accuracy of risk assessment and facilitates the use of therapy choices.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Oncology Research and Treatment.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Oncology Research and Treatment
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Gihan Hamasharif Hamad”